Recent Finacing
Recent Raise
Terumo BCT develops blood-product technologies centered on the Mirasol Pathogen Reduction Technology and runs multicenter trials evaluating Mirasol-treated platelets; Mirasol PRT is investigational in the US and Canada.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor